Puluo Pharmaceutical: Plans to repurchase shares worth 180-360 million yuan for incentive plan.

Puro Pharmaceuticals announced that the company plans to repurchase shares through centralized bidding, for use in equity incentives or employee stock ownership plans. If not implemented within 36 months, the unutilized portion will be canceled. The total amount of repurchase funds is between 180 million and 360 million yuan, with a repurchase price not exceeding 23 yuan per share. It is expected to repurchase 7.83 million to 15.65 million shares, accounting for 0.68% to 1.35% of the total share capital. The repurchase period is 12 months from the date of approval by the board of directors, and the funds come from internal resources and financial institution loans. As of the announcement date, shareholders holding more than 5% of the shares have no plans to reduce their holdings. This repurchase carries risks related to price and implementation of the plan.